Top 5 Biotechnology Angel Investors in New Zealand in January 2026
A list of 5 angel investors that invest in Biotechnology startups based in New zealand. We rank investors based on the number of investments they made in Biotechnology companies from New zealand. We update this investor list every month.Top 5 Biotechnology Angel Investors in New Zealand in January 2026
| Investor | Biotechnology New Zealand investments |
|---|---|
| Paul Davidson | 1 |
| Marko Bogoievski | 1 |
| Serge van Dam | 1 |
| Melanie Melanie | 1 |
| David Ross | 1 |
Paul Davidson joined private equity group, West Coast Capital in 2005 following a successful career in corporate law in the UK, the US and Commonwealth of Independent States. As an active partner in West Coast Capital as well as providing legal counsel, Paul focusses on deal sourcing and transacting.Since joining the group, Paul has successfulyled the acquisition and delisting from the LSE of the UK's largest garden centre business, Wyevale as well as a series of acquisitions and disposals.Prior to joining West Coast Capital headed the corporate team of UK lawyers, McGrigors.In late 1994 Paul was seconded to an oil and gas company called JKX whose focus was on the former Soviet Union, primarily in Ukraine, Georgia and the Russian Federation. JKX listed on the London Stock Exchange in mid 1995 and at that time Paul joined the company as its Legal Director on a full time basis. During his time as Legal Director, Paul gained wide commercial experience as the company concluded a number of transactions throughout the former Soviet Union.
Show more
Investment focus
- SaaS, FinTech, Privacy
- Seed, Series A, Series B
- Finland, New Zealand, United Kingdom
Portfolio highlights
- Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
- TVSquared — With trusted, independent attribution and partnerships with DSPs, publishers, advertisers and MVPDs, TVSquared measures the effectiveness of TV advertising through an infinitely scalable platform for linear, addressable and OTT/CTV.
- Ubisecure — Ubisecure B2B IAM, Legal Entity Identifiers LEI, IDaaS and hybrid identity management. European SSO, MFA, LEI made easy.
Marko retired as CEO of Morrison & Co in 2021 after 13 years of leading the business. He continues to provide guidance for investments in telecommunications and digital infrastructure. His 30 year career has been in the infrastructure and technology sectors in a variety of senior finance, operational and sales roles in the United States and NewZealand. Prior to joining Morrison & Co in 2008, Marko was CFO of Telecom NZ, responsible for corporate finance, M&A and group strategy. Marko is Chair of Vodafone New Zealand.
Show more
Investment focus
- Biotechnology, Manufacturing
- Funding Round
- New Zealand
Portfolio highlights
- Pictor — PictorDx offers a flexible multiplex proteomics platform that delivers multiple biomarker insights simultaneously and cost-effectively for multiple sample types
Serge has a depth of experience in technology startups that is difficult to rival. As CMO of M-Com, Serge led the growth of M-Com from a four person mobile commerce development company to the world's most successful provider of mobile banking and payment solutions (in both licensed and SaaS categories). He has since held executive levelpositions and Directorships, including as Chair on four boards, of many successful B2B SaaS companies. He is also an avid investor.
Show more
Investment focus
- Biotechnology, Product Research
- Seed
- New Zealand
Portfolio highlights
- Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
Investor
Show more
Investment focus
- Biotechnology, Product Research
- Seed
- New Zealand
Portfolio highlights
- Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
David Ross
Show more
Investment focus
- Biopharma, Biotechnology
- Seed
- New Zealand
Portfolio highlights
- Helico — Helico is developing a proprietary computational platform for synthetic biology research using modelling tools and AI-based prediction algorithms. The long-term aim is to develop a seed bank of different drugs able to be licensed to grow medical supplies in confined greenhouses anywhere in the world.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
EdTech
Sustainability
Health Care
Venture Capital
Clean Energy
Web3
Organic Food
Big Data
Video Games
Publishing
B2B
Food and Beverage
Payments
Real Estate
Finance
Education
Financial Services
Art
Retail
Infrastructure
Beauty
Photography
Biotechnology
Travel
Fitness
Recruiting
Hospitality
Mobile Advertising
Platforms
Cannabis
Wellness
Automotive
Social
Wine And Spirits
Android
Medical Device
Crowdfunding
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
Digital Media
Manufacturing
LGBT
Construction
Sports
Franchise
eSports
Mobile
Oil and Gas
Fashion
Enterprise Software
Music
Film
Life Science
Theatre
Email
Social Media
Social Network
Medical
Non Profit
Legal
Local
Internet
Renewable Energy
SaaS
Restaurants
Sporting Goods
Software
Celebrity
Social Impact
Cryptocurrency
Machine Learning
Blockchain
Agriculture (agtech)
Media (entertainment)
Facebook
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Sri Lanka
Vietnam
Europe
Qatar
Japan
Ghana
Egypt
Singapore
Belarus
Hungary
Spain
Finland
France
China
Croatia
Armenia
Gibraltar
Barbados
Georgia
Saudi Arabia
Greece
Czech Republic
Oceania
Faroe Islands
Costa Rica
Hong Kong
Bahrain
Belgium
Denmark
Africa
Bermuda
Estonia
LATAM
Algeria
Ecuador
Asia
Bulgaria
Belize
Chile
Brazil
Ethiopia
Liechtenstein
Panama
Myanmar
Lithuania
Malaysia
Togo
Peru
Liberia
Jersey
Lebanon
Rwanda
Norway
Mexico
Italy
Slovenia
Mali
Philippines
Israel
Kuwait
Mauritius
Poland
Malta
Morocco
Nicaragua
Dominican Republic
Uganda
Bahamas
Iraq
Iceland
San Marino
Sweden
Azerbaijan
Nigeria
Namibia
Serbia
United Arab Emirates
Jamaica
Sierra Leone
Thailand
Honduras
Isle of Man
Bolivia
Tanzania
Luxembourg
Pakistan
Albania
Uzbekistan
Zambia
Turkey
Romania
Jordan
Uruguay
Grenada
Argentina
Bangladesh
Tajikistan
Russian Federation
Portugal
El Salvador
Puerto Rico
Senegal
Zimbabwe
Tunisia
Venezuela
Ukraine
Taiwan
Kazakhstan
Kenya
Cambodia
Cayman Islands
Cyprus
Oman
Latvia
Cameroon
Austria
Switzerland
Guatemala
Colombia
Marshall Islands
Seychelles
Angel Investors in New Zealand by industry
Proptech
SaaS
Marketplace
Climate
Enterprise Software
Mobile Apps
Real Estate
Web3
Enterprise
Internet
Software
Biotechnology
FinTech
Health Care
Artificial intelligence
Education
Consumer
EdTech
Blockchain
Platforms
Financial Services
Transportation
Biotech
Hardware
Media (entertainment)
Payments
Facebook
Machine Learning
Mobile
Community
Gaming